Welcome to our dedicated page for Abacus Global Management news (Ticker: ABL), a resource for investors and traders seeking the latest updates and insights on Abacus Global Management stock.
Abacus Life Inc (NASDAQ: ABL) generates news primarily related to the life settlements industry, where the company operates by purchasing life insurance policies from policyholders seeking liquidity. As a participant in this specialized financial services segment, ABL's news flow typically includes developments in policy acquisition activity, industry regulatory changes, and competitive dynamics within the secondary life insurance market.
News about Abacus Life often covers topics unique to life settlement providers, including actuarial developments, life expectancy estimation methodologies, and litigation that occasionally arises in this sector. The company's positioning in the Finance and Insurance sector means its news frequently intersects with broader insurance industry trends and alternative asset class developments.
Investors tracking ABL stock will find coverage of material events disclosed through SEC filings, including 8-K announcements about business developments, financial results, and corporate actions. The life settlements industry generates news around regulatory developments at the state level, as licensing requirements and consumer protection rules evolve across different jurisdictions.
This news page aggregates coverage of Abacus Life's business operations, competitive positioning against other life settlement providers, and industry-wide developments affecting the secondary market for life insurance policies. Bookmark this page to follow ABL-related news as developments occur in this niche financial services sector.
Abacus Global Management (NASDAQ: ABL), a leader in alternative asset management, has filed a lawsuit against Coventry First LLC and its Chairman Alan Buerger for defamation and anticompetitive conduct in Florida's Ninth Circuit Court. The lawsuit alleges that Coventry and Buerger orchestrated a systematic campaign to spread false information about Abacus's valuation practices, culminating in a short report by Morpheus Research on June 4, 2025.
The legal action details how Coventry's campaign led to a 21% drop in Abacus's stock price, erasing over $200 million in market capitalization. Abacus claims Coventry spread misleading information to regulators, auditors, analysts, and investors, particularly regarding Abacus's use of Lapetus Solutions for life expectancy estimates.
Abacus CEO Jay Jackson emphasizes that the company's transparent pricing model has been validated by market transactions, with policies consistently selling to sophisticated investors like KKR at prices exceeding Abacus's valuations. The company is seeking hundreds of millions in damages for harm to its reputation, customer base, and investor relationships.
Abacus Global Management (NASDAQ: ABL) has launched an exchange offer and consent solicitation for its outstanding public and private placement warrants. The company is offering 0.23 shares of common stock for each warrant tendered, with a total offering of up to 4,743,381 shares of common stock in exchange.
The exchange offer will run until July 29, 2025. Concurrently, Abacus is seeking consent to amend the warrant agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% reduction from the current offer ratio. Currently, parties representing 25% of public warrants and 94% of private placement warrants have agreed to the exchange.
As of June 30, 2025, Abacus has 97,867,821 shares of common stock outstanding and 20,623,395 total warrants. If all warrant holders participate, the company would issue approximately 4.7 million new shares, increasing the total outstanding shares by about 5% to 102,611,202.
Abacus Global Management (NASDAQ: ABL) has announced plans to conduct an exchange offer and consent solicitation for its outstanding warrants. The company is offering 0.23 shares of common stock for each warrant tendered in the exchange. Additionally, ABL is seeking consent to amend the Warrant Agreement to require remaining warrant holders to exchange their warrants for 0.207 shares of common stock, a 10% lower ratio than the initial offer.
Currently, each warrant allows holders to purchase one common share at $11.50 per share. The amendment would require approval from at least 50% of public warrant holders. The exchange offer will commence following the filing of a Form S-4 registration statement.
Abacus Global Management (NASDAQ: ABL) has announced the details for its upcoming virtual Abacus Investor Day and Longevity Summit, scheduled for Thursday, June 12th, 2025. The event will run from 9:30 AM ET to 12:45 PM ET and will be accessible via livestream.
This specialized one-day event will focus on integrating lifespan considerations into financial products. The summit will feature presentations on the company's business model, current ABL products, and future outlook. Additionally, leading experts in longevity and lifespan will discuss how human longevity impacts financial planning strategies.
Abacus Global Management (NASDAQ: ABL) reported strong Q1 2025 financial results, with total revenue more than doubling to $44.1 million compared to $21.5 million in Q1 2024. The company achieved GAAP net income of $4.6 million, reversing a $1.3 million loss from the previous year. Adjusted net income grew 158% to $17.3 million, while Adjusted EBITDA doubled to $24.5 million with a 55.6% margin.
Key highlights include $122.8 million in capital inflows to their Longevity Funds and origination capital deployment of $124.9 million. The company's policy portfolio expanded to 753 policies, up from 322 year-over-year. Abacus maintains its 2025 outlook for Adjusted net income between $70-78 million, projecting 51-68% growth compared to 2024.
Abacus Global Management (NASDAQ: ABL), a leader in alternative asset management, has scheduled its Q1 2025 financial results announcement for Thursday, May 8, 2025, after market close. The company will host a conference call at 5:00 pm Eastern Time on the same day to discuss the results.
Investors can access the live webcast through the company's investor relations website at ir.abacusgm.com. For those preferring phone access, toll-free dial-in is available at (877) 407-9716, with international callers using (201) 493-6779. Participants are advised to dial in 10 minutes before the scheduled start time. A replay of the webcast will remain accessible on the company's IR website for one year following the call.